Adia Nutrition (ADIA) Depreciation & Amortization (CF) (2025 - 2026)
Adia Nutrition's (ADIA) quarterly Depreciation & Amortization (CF) came in at $1251.0 in Q1 2026, up 61.63% year-over-year from $774.0 in Q1 2025, and up 61.63% quarter-over-quarter from $774.0 in Q1 2025.
Powered by 
Analysis
Adia Nutrition (ADIA) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Depreciation & Amortization (CF) for 2 consecutive years, with $1251.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 61.63% year-over-year to $1251.0 in Q1 2026; TTM through Jun 2026 was $2025.0, a N/A change from a year earlier, with the FY2025 full-year figure at $4142.0, up 856.58% from the prior year.
- Depreciation & Amortization (CF) was $1251.0 for Q1 2026 at Adia Nutrition, up from $774.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $1251.0 in Q1 2026 and troughed at $774.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | 4.28 Mn |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | 3.78 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 4.00 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 4.91 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 1.10 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | 5.41 Mn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | 10.41 Mn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 3.62 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |